The prevalence of antibiotic resistance in anaerobic bacteria isolated from patients with skin infections

Gene Therapy and Molecular Biology

Volumn 10, Issue 2, 2006, Pages 263-267

  Eslami, Gita ^a   Fallah, Fatemeh ^a   Goudarzi, Hossein ^a   Navidinia, Masoumeh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anaerobic bacteria; Antibiotic resistance; Skin infection

Indexed keywords

BACTERIA (MICROORGANISMS); BACTEROIDES; BACTEROIDES (CLASS); CITROBACTER; CLOSTRIDIUM; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FUSOBACTERIUM; PEPTOSTREPTOCOCCUS; PREVOTELLA; PROTEUS (ENTEROBACTERIA); PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS SP. 'GROUP A';

EID: 47149089694     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Brook I (1995) Microbiology of secondary bacterial infection in scabies lesions. J Clin Microbiol 33, 2139-2140.
2. Brook I, Frazier EH, Yeager JK (1997) Microbiology of nonbullous impetigo. Pediatr Derinatol 14, 192-5.
3. Bryskier A (2001) Anti-anaerobic activity of antibacterial agents. Expert Opin Investig Drugs 10, 239-67.
4. Caceres M, Carrera E, Palma A, Berrios G, Weintraub A, Nord CE (1999) Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua. Rev Esp Quimioter 12, 332-9.
5. Chau JC (1999) Combating bacterial resistance in skin and skin-structure infection: importance of β-lactamase inhibition. Am J Ther 6, 13-18.
6. Finegold SM (1995) Anaerobic infections in humans: an overview. Anaerobe 1, 3-9.
7. Goldstein EJ, Citron DM, Merriam CV, Warren Y, Tyrrell KL, Gesser RM (2002) General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin-structure infections from complicated skin and skin -structure infections in patients enrolled in a comparative trail of eratapennem versus piperacillin-tazobactam. Clin Infect Dis 35(suppl 1):S119-25.
8. Holten KB, Onusko EM (2000) Appropriate prescribing of oral β-lactam antibiotics. Am Fam Physician 62, 611-20.
9. Nichols RL, Graham DR, Barriere SL, Rodgers A, Wilson SE, Zervos M, Dunn DL, Kreter B (1999) Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group. J Antimicrob Chemother 44, 263-73.
10. Summanen PH, Talan DA, Strong C, McTeague M, Bennion R, Thompson JE, Vaisanen ML, Moran G, Winer M, Finegold SM (1995) The bacteriology of skin and soft tissue infections: a comparison of infections in intravenous drug abusers and nonintravenous drug abusers. Clin Infect Dis 20 (Suppl 2), S279-S282.
11. Ueno K, Kato N, Kato H (2002) The status of research on anaerobes in Japan. Clin Infect Dis 35 (supply 1), 828-35.
12. Wexler HM, Molitoris E, Molitoris D, Finegold SM (1998) In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections. Antimicrob Agents Chemother 42, 984-6.
13. Wexler HM, Finegold SM (1998) Current susceptibility patterns of anaerobic bacteria. Yonsei Med J 39, 495-501.